ShanXi C&Y Pharmaceutical Group Co.,LTD. (SHE:300254)
China flag China · Delayed Price · Currency is CNY
13.50
+0.69 (5.39%)
Apr 30, 2026, 3:08 PM CST

SHE:300254 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
3,4572,1732,3271,6361,9811,571
Market Cap Growth
39.07%-6.62%42.24%-17.43%26.13%-7.02%
Enterprise Value
3,9652,3522,5791,7732,2481,769
Last Close Price
13.508.759.636.778.696.89
PE Ratio
162.0551.5092.35---
Forward PE
-47.4847.4847.4847.4847.48
PS Ratio
4.072.572.911.972.131.85
PB Ratio
5.993.632.992.242.661.80
P/TBV Ratio
--25.9332.4868.4921.65
P/FCF Ratio
53.84111.77596.9134.0133.02-
P/OCF Ratio
41.5130.6361.5321.8520.44-
EV/Sales Ratio
4.672.783.232.142.422.09
EV/EBITDA Ratio
29.9620.6633.2051.1763.24-
EV/EBIT Ratio
52.1837.35102.75---
EV/FCF Ratio
61.75120.98661.6236.8737.47-
Debt / Equity Ratio
0.910.520.290.400.310.35
Debt / EBITDA Ratio
3.982.582.717.025.92-
Debt / FCF Ratio
8.2016.0358.036.013.83-
Net Debt / Equity Ratio
0.690.270.120.030.160.14
Net Debt / EBITDA Ratio
3.161.421.210.723.44-0.88
Net Debt / FCF Ratio
6.198.3424.170.522.04-2.24
Asset Turnover
0.550.570.530.530.560.47
Inventory Turnover
2.222.232.322.372.512.09
Quick Ratio
0.620.600.630.630.630.87
Current Ratio
0.920.880.960.850.941.18
Return on Equity (ROE)
7.85%10.86%6.46%-13.28%-9.22%-31.08%
Return on Assets (ROA)
3.09%2.64%1.04%-0.95%-1.06%-6.88%
Return on Invested Capital (ROIC)
5.36%7.15%2.72%-2.92%-3.03%-18.65%
Return on Capital Employed (ROCE)
7.70%6.40%2.50%-2.40%-2.50%-15.10%
Earnings Yield
0.59%1.94%1.08%-7.25%-4.62%-16.70%
FCF Yield
1.86%0.90%0.17%2.94%3.03%-3.33%
Payout Ratio
90.75%29.20%52.84%---
Buyback Yield / Dilution
-1.13%-0.20%-1.89%-4.00%-6.92%-2.25%
Total Shareholder Return
-1.13%-0.20%-1.89%-4.00%-6.92%-2.25%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.